JP2010162016A5 - - Google Patents

Download PDF

Info

Publication number
JP2010162016A5
JP2010162016A5 JP2009256885A JP2009256885A JP2010162016A5 JP 2010162016 A5 JP2010162016 A5 JP 2010162016A5 JP 2009256885 A JP2009256885 A JP 2009256885A JP 2009256885 A JP2009256885 A JP 2009256885A JP 2010162016 A5 JP2010162016 A5 JP 2010162016A5
Authority
JP
Japan
Prior art keywords
polypeptide
antibody
seq
cell
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009256885A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010162016A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2010162016A publication Critical patent/JP2010162016A/ja
Publication of JP2010162016A5 publication Critical patent/JP2010162016A5/ja
Pending legal-status Critical Current

Links

JP2009256885A 2002-09-25 2009-11-10 乾癬の治療のための新規組成物と方法 Pending JP2010162016A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41400602P 2002-09-25 2002-09-25

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004540290A Division JP2006513700A (ja) 2002-09-25 2003-09-25 乾癬の治療のための新規組成物と方法

Publications (2)

Publication Number Publication Date
JP2010162016A JP2010162016A (ja) 2010-07-29
JP2010162016A5 true JP2010162016A5 (enExample) 2011-02-10

Family

ID=32043325

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004540290A Pending JP2006513700A (ja) 2002-09-25 2003-09-25 乾癬の治療のための新規組成物と方法
JP2009256885A Pending JP2010162016A (ja) 2002-09-25 2009-11-10 乾癬の治療のための新規組成物と方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004540290A Pending JP2006513700A (ja) 2002-09-25 2003-09-25 乾癬の治療のための新規組成物と方法

Country Status (6)

Country Link
US (3) US20070042945A1 (enExample)
EP (2) EP1585482A4 (enExample)
JP (2) JP2006513700A (enExample)
AU (2) AU2003279084A1 (enExample)
CA (1) CA2499843A1 (enExample)
WO (1) WO2004028479A2 (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7638284B2 (en) * 2000-10-31 2009-12-29 The Curators Of The University Of Missouri Immunoglobulin A inducing protein and uses therefor
US7449548B2 (en) * 2001-12-07 2008-11-11 Agensys, Inc. Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
US7803906B2 (en) * 2002-03-22 2010-09-28 Gene Signal International Sa Composition comprising an angiogenesis related protein
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
CA2499843A1 (en) * 2002-09-25 2004-04-08 Genentech, Inc. Novel compositions and methods for the treatment of psoriasis
CA2508948A1 (en) 2002-12-16 2004-07-15 Halozyme, Inc. Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof
US7749695B2 (en) * 2003-03-03 2010-07-06 Alexander Abbas PRO polypeptides for diagnosis of systemic lupus erythematosis
CA2518552A1 (en) * 2003-03-11 2004-09-23 Genentech, Inc. Novel compositions and methods for the treatment of immune related disease
JP3983260B2 (ja) 2003-07-09 2007-09-26 塩野義製薬株式会社 アトピー性皮膚炎誘引物質
WO2005019258A2 (en) * 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US7473541B2 (en) * 2004-07-09 2009-01-06 Gross Richard W Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities
US7723497B2 (en) * 2003-12-11 2010-05-25 Washington University In St. Louis Human IPLA2ε
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
US7960100B1 (en) 2004-04-30 2011-06-14 Celera Corporation Colon cancer targets and uses thereof
US20090253770A1 (en) * 2004-05-18 2009-10-08 Kurume University Target gene mimitin of myc
GB0414325D0 (en) * 2004-06-25 2004-07-28 Celltech R&D Ltd A protein involved in cancer
WO2006017171A2 (en) * 2004-07-13 2006-02-16 Metabolex, Inc. Methods of diagnosing & treating obesity, diabetes and insulin resistance
EP1831370A4 (en) * 2004-12-13 2009-08-12 Alethia Biotherapeutics Inc POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN BONE RESOLUTION
WO2006090389A2 (en) 2005-02-24 2006-08-31 Compugen Ltd. Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
WO2007030820A2 (en) * 2005-09-09 2007-03-15 The Johns Hopkins University Manipulation of regulatory t cell and dc function by targeting neuritin gene using antibodies, agonists and antagonists
ES2543341T3 (es) 2005-09-13 2015-08-18 National Research Council Of Canada Métodos y composiciones para modular la actividad de células tumorales
WO2007036022A1 (en) * 2005-09-27 2007-04-05 National Research Council Of Canada Targeted delivery of compounds using multimerization technology
DE102005059242A1 (de) 2005-12-12 2007-06-14 Johannes Gutenberg-Universität Mainz, Vertreten Durch Den Präsidenten Molekulare Marker für eine Tumordiagnose und -therapie
CN101389769A (zh) * 2005-12-28 2009-03-18 森托科尔公司 用于评价和治疗银屑病及相关疾病的标记与方法
EP1994172A4 (en) * 2006-03-07 2009-11-18 Telethon Inst For Child Health METHOD FOR THE DIAGNOSIS AND / OR PREDICTION OF THE DEVELOPMENT OF ALLERGIC DISEASE AND AGENTS FOR TREATMENT AND / OR PREVENTING THEREOF
FR2908784B1 (fr) * 2006-11-17 2012-12-14 Oreal Utilisation cosmetique d'une proteine de la famille des ribonucleases
FR2908654B1 (fr) 2006-11-20 2014-04-04 Oreal Utilisation cosmetique de proteines de type chitinase
EP2101567A4 (en) * 2007-01-18 2010-04-21 Univ Utah Res Found COMPOSITIONS AND METHODS FOR DETECTING, TREATING OR PREVENTING REDUCED STRESS
CN101688205B (zh) 2007-05-16 2013-07-24 基因信号国际公司 抗肿瘤药物、药剂、组合物及其用途
EP2781223B1 (en) * 2007-10-19 2017-02-22 Rappaport Family Institute for Research in the Medical Sciences Compositions comprising semaphorins for use in the treatment of cancer
US9808506B2 (en) 2007-10-19 2017-11-07 Rappaport Family Institute For Research In The Medical Sciences Compositions comprising semaphorins for the treatment of cancer and methods of selection thereof
US8168586B1 (en) 2007-11-21 2012-05-01 Celera Corporation Cancer targets and uses thereof
FR2925314B1 (fr) * 2007-12-19 2012-11-23 Oreal Utilisation cosmetique de proteines de type transglutaminase 3
DE102008033381B4 (de) * 2008-07-07 2013-12-24 Alexander Steinle Modulation der Immunantwort durch den Rezeptor NKp65 und seine Liganden
EA034462B1 (ru) 2009-11-24 2020-02-11 Алетиа Байотерапьютикс Инк. Антикластериновые антитела и антигенсвязывающие фрагменты и их использование для уменьшения объема новообразований
WO2011106839A1 (en) * 2010-03-03 2011-09-09 Children's Cancer Institute Australia for Medical Research Skin cancer prevention and treatment
US9822170B2 (en) 2012-02-22 2017-11-21 Alethia Biotherapeutics Inc. Co-use of a clusterin inhibitor with an EGFR inhibitor to treat cancer
CA2877721A1 (en) 2012-06-27 2014-01-03 Berg Llc Use of markers in the diagnosis and treatment of prostate cancer
GB201300684D0 (en) 2013-01-15 2013-02-27 Apitope Int Nv Peptide
US10201610B2 (en) * 2014-10-20 2019-02-12 The University Of Western Australia Interference peptides and use thereof
US10539566B2 (en) 2014-12-08 2020-01-21 Berg Llc Use of markers including filamin A in the diagnosis and treatment of prostate cancer
EP3271024A4 (en) * 2015-03-20 2018-12-05 The Trustees of the University of Pennsylvania Isg15 and its use as an adjuvant
CA3120474A1 (en) 2018-12-21 2020-06-25 23Andme, Inc. Anti-il-36 antibodies and methods of use thereof
KR102065171B1 (ko) * 2019-02-20 2020-01-13 (주)케어젠 대기오염물질에 의한 피부 손상 방지 및 항노화용 펩타이드와 이의 용도
CN112175949B (zh) * 2020-09-23 2021-05-04 山东大学第二医院 lncRNA RP11-394O4.6在抑制膀胱癌细胞生物学功能中的应用
WO2024246046A1 (en) 2023-05-31 2024-12-05 Corequest Sagl Gene delivery to cells of vectors comprising crat nucleotidic or aminoacidic sequences

Family Cites Families (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
FR2413974A1 (fr) 1978-01-06 1979-08-03 David Bernard Sechoir pour feuilles imprimees par serigraphie
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
NZ201705A (en) 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4943529A (en) 1982-05-19 1990-07-24 Gist-Brocades Nv Kluyveromyces as a host strain
AU2353384A (en) 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4675187A (en) 1983-05-16 1987-06-23 Bristol-Myers Company BBM-1675, a new antibiotic complex
DD266710A3 (de) 1983-06-06 1989-04-12 Ve Forschungszentrum Biotechnologie Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
AU3145184A (en) 1983-08-16 1985-02-21 Zymogenetics Inc. High expression of foreign genes in schizosaccharomyces pombe
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
EP0206448B1 (en) 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hemoglobin combined with a poly(alkylene oxide)
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
WO1987005330A1 (en) 1986-03-07 1987-09-11 Michel Louis Eugene Bergh Method for enhancing glycoprotein stability
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US4946783A (en) 1987-01-30 1990-08-07 President And Fellows Of Harvard College Periplasmic protease mutants of Escherichia coli
US5223425A (en) * 1987-04-02 1993-06-29 The Beth Israel Hospital Association DNA encoding human adipsin with complement D activity
US5010182A (en) 1987-07-28 1991-04-23 Chiron Corporation DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
GB8724885D0 (en) 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
KR0154872B1 (ko) 1987-12-21 1998-10-15 로버트 에이. 아미테이지 발아하는 식물종자의 아크로박테리움 매개된 형질전환
AU4005289A (en) 1988-08-25 1990-03-01 Smithkline Beecham Corporation Recombinant saccharomyces
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
ES2038579T3 (es) 1989-04-28 1997-02-16 Rhein Biotech Proz & Prod Gmbh Celulas de levadura del genero schwanniomyces.
FR2646437B1 (fr) 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
ES2096590T3 (es) 1989-06-29 1997-03-16 Medarex Inc Reactivos biespecificos para la terapia del sida.
FR2649120B1 (fr) 1989-06-30 1994-01-28 Cayla Nouvelle souche et ses mutants de champignons filamenteux, procede de production de proteines recombinantes a l'aide de ladite souche et souches et proteines obtenues selon ce procede
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
WO1992000373A1 (en) 1990-06-29 1992-01-09 Biosource Genetics Corporation Melanin production by transformed microorganisms
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
US5206161A (en) 1991-02-01 1993-04-27 Genentech, Inc. Human plasma carboxypeptidase B
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
ATE207080T1 (de) 1991-11-25 2001-11-15 Enzon Inc Multivalente antigen-bindende proteine
DK0752248T3 (da) 1992-11-13 2000-11-13 Idec Pharma Corp Terapeutisk anvendelse af kimæriske og radioaktivt mærkede antistoffer mod humant B-lymfocytbegrænset differentieringsantig
PT616812E (pt) 1993-03-24 2000-04-28 Berlex Biosciences Combinacao de compostos anti-hormonais e moleculas de ligacao no tratamento do cancro
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US6458939B1 (en) 1996-03-15 2002-10-01 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation
WO2002008284A2 (en) * 2000-07-20 2002-01-31 Genentech, Inc. Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
US5863769A (en) * 1997-01-28 1999-01-26 Smithkline Beecham Corporation DNA encoding interleukin-1 receptor antagonist (IL-1raβ)
JPH10221340A (ja) * 1997-02-07 1998-08-21 Advanced Sukin Res Kenkyusho:Kk 皮膚疾患の診断方法および薬効評価方法
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP4437192B2 (ja) * 1998-02-20 2010-03-24 タノックス インコーポレイテッド 補体活性化阻害剤
AU5772299A (en) * 1998-08-07 2000-02-28 Millennium Pharmaceuticals, Inc. Novel molecules of the tango-93-related protein family and uses thereof
AU6296899A (en) * 1998-10-08 2000-04-26 Zymogenetics Inc. Interleukin-1 homolog
EP1141299A2 (en) * 1998-12-23 2001-10-10 Genentech, Inc. Il-1 related polypeptides
US20020076762A1 (en) * 1999-05-14 2002-06-20 Incyte Pharmaceuticals, Inc. Full-length expressed genetic markers
FR2797402B1 (fr) * 1999-07-15 2004-03-12 Biomerieux Stelhys Utilisation d'un polypeptide pour detecter, prevenir ou traiter un etat pathologique associe a une maladie degenerative, neurologique ou autoimmune
EP1200593A2 (en) * 1999-07-16 2002-05-02 Interleukin Genetics, Inc. The il-1l1 gene and polypeptide products
CA2491433A1 (en) * 1999-12-01 2001-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP2005520479A (ja) * 2000-05-09 2005-07-14 ジェネティクス インスティテュート，エルエルシー 乾癬の確認、評価、予防および治療のための組成物、キットおよび方法
MXPA02012717A (es) * 2000-06-21 2003-09-22 Amgen Inc Polipeptidos estromaticos-1 del colon, epiteliales, secretados, acidos nucleicos que los codifican y sus usos.
CA2499843A1 (en) * 2002-09-25 2004-04-08 Genentech, Inc. Novel compositions and methods for the treatment of psoriasis

Similar Documents

Publication Publication Date Title
JP2010162016A5 (enExample)
CA2771441C (en) Antibodies for the detection of integrin complexes in ffpe material
JP2005046146A5 (enExample)
CA2479494A1 (en) Compositions and methods associated with pro5725 and its use for the diagnosis of lung and colon tumor
JP2006516094A5 (enExample)
KR102019008B1 (ko) 메르스 코로나바이러스 뉴클레오캡시드 융합 단백질을 이용한 메르스 코로나바이러스 검출 방법
JP2006223304A5 (enExample)
JP2006081548A5 (enExample)
CA2503125A1 (en) Novel composition and methods for the treatment of immune related diseases
WO2008103849A4 (en) Methods and compounds for lymphoma cell detection and isolation
HK1221490A1 (zh) 以生物樣品進行的針對igfbp7的具有改進的性能的測定
AU2011261308A1 (en) Markers for renal disease
JP2005027667A5 (enExample)
RU2013142334A (ru) КОМПОЗИЦИИ И СПОСОБЫ ПРИМЕНЕНИЯ ДЛЯ ОПРЕДЕЛЕНИЯ НЕ4а
JP2006518582A5 (enExample)
RU2018138782A (ru) Антитела к фактору ix padua
JP2006521810A5 (enExample)
JP2006521082A5 (enExample)
JP2005518212A5 (enExample)
JP5580967B2 (ja) ブタ繁殖性呼吸器症候群ウイルスに対する抗体を検出するためのペプチド
JP2005502344A5 (enExample)
EP4293360A1 (en) Adult still's disease inspection method and inspection kit
JP2003527844A5 (enExample)
JP2010029191A5 (enExample)
WO2019081912A1 (en) ANTIGENS OF THE RECEPTOR OF A2 PHOSPHOLIPASE AND THEIR MEDICAL USE